Obesity and technology: Can the stomach be fooled?
WEIGHT CONTROL
By Debra Sherman
Yahoo News, Wed Apr 26, 3:39 PM ET
"MINNEAPOLIS (Reuters) - The company that invented the heart pacemaker is employing the same technology to trick obese patients into thinking their stomachs are full."
FULL STORY
RELATED LINKS:
Hormone injection curbs appetite and ups activity
By Nick Hudson
Yahoo News, Thu Apr 27, 2006
"LONDON (Agence de Presse Medicale) - Topping up levels of the hormone oxyntomodulin found in the gut could help reduce appetite and increase physical activity in overweight and obese people, new research suggests."
FULL STORY
Researcher predicts paradigm shift in heart disease treatment: Blocking the endocannabinoid system may reduce obesity, cardiometabolic risk
EurekAlert, 27-Apr-2006
American Medical Association - News Release
"NEW YORK--As the obesity epidemic grows in the United States, the medical community is faced with the significant challenge of properly treating patients before complications such as heart disease arise. But, as obesity expert Louis Aronne, MD, explained, ongoing research into the endocannabinoid (EC) system shows promise in combating obesity and the associated cardiometabolic risks."
FULL RELEASE
By Debra Sherman
Yahoo News, Wed Apr 26, 3:39 PM ET
"MINNEAPOLIS (Reuters) - The company that invented the heart pacemaker is employing the same technology to trick obese patients into thinking their stomachs are full."
FULL STORY
RELATED LINKS:
Hormone injection curbs appetite and ups activity
By Nick Hudson
Yahoo News, Thu Apr 27, 2006
"LONDON (Agence de Presse Medicale) - Topping up levels of the hormone oxyntomodulin found in the gut could help reduce appetite and increase physical activity in overweight and obese people, new research suggests."
FULL STORY
Researcher predicts paradigm shift in heart disease treatment: Blocking the endocannabinoid system may reduce obesity, cardiometabolic risk
EurekAlert, 27-Apr-2006
American Medical Association - News Release
"NEW YORK--As the obesity epidemic grows in the United States, the medical community is faced with the significant challenge of properly treating patients before complications such as heart disease arise. But, as obesity expert Louis Aronne, MD, explained, ongoing research into the endocannabinoid (EC) system shows promise in combating obesity and the associated cardiometabolic risks."
FULL RELEASE